The role of salivary cytokine biomarkers in tongue cancer invasion and mortality
Introduction
Despite advances in cancer detection and treatment, the prognosis of squamous cell carcinoma of the tongue (TSCC) has not improved in the last few decades and remains one of the most common and fatal head and neck cancers worldwide.1 Studies have found that the tongue is the most common site for squamous cell carcinoma of the oral cavity and oropharynx (OSCC), comprising around 41%.3 Of particular concern is the rising incidence in the population and the significant increase of TSCC in patients under 40 years of age.2, 4
TSCC has been found to have a poorer prognosis when compared to similar stage lesions in other locations.1 Studies have shown that a T2 TSCC lesion has a worse prognosis than T3/T4 oropharyngeal tumors.1 These results are attributed to the higher recurrence rate, poorer locoregional control, and early nodal metastasis.5, 6, 7, 8 Metastasis has been found to be the single most important predictor of prognosis and is unfortunately present on diagnosis 40% of the time.9 This is partially attributable to the lack of screening mechanisms for TSCC and therefore the increased frequency of cases that present at advanced stage.10
These unfortunate aspects of TSCC point to early detection as the key for improving outcomes, especially for high risk groups that smoke tobacco and drink alcohol.11 One method for early detection is biomarker technology, based on the research indicating that mutations present in primary tumors can also be found in the fluids that drain the affected organ, often before the cancer phenotype is expressed.12 Previous research has identified both nucleic acid and protein biomarkers that are elevated in the serum of patients with OSCC including proinflammatory cytokines interleukins 1, 6 and 8 (IL-1, IL-6 and IL-8).13, 14, 15 In a comparison of up-regulated genes in OSCC, Ye et al. found a roughly 5.8-fold increase in IL-8 genomic expression and 2.5-fold increase in TNF-α expression.14 On a proteomic level, IL-6 has been shown to have up to an 80-fold increase in serum of OSCC patients.13 Chen et al. also found significantly elevated protein levels of IL-6, IL-8 and vascular endothelial growth factor (VEGF) to be secreted by OSCC tumor cell cultures, indicating the elevated cytokine levels are not merely a stromal response to cancer presence. They supported the potential for these cytokines as OSCC biomarkers by finding these levels to be elevated above that of patients with benign squamous papilloma.15
These cytokines have also been found to be elevated in the saliva of OSCC patients.13, 16, 17 In our collaboration with St John et al., we identified significantly elevated levels of IL-8 protein and mRNA in the saliva of OSCC patients as well as increased IL-6 in the serum of the same group.13 Based on our previous evidence, we chose the same cytokine set to further examine their role as biomarkers in screening and diagnosis. Saliva is non-invasive, easily and efficiently accessed, and in direct contact with the oral mucosa and cancerous lesions. It therefore has the potential for widespread screening and detection of early lesions. If levels of cytokines increase with disease progression, salivary biomarkers also have the potential for prognostic determination or recurrence detection. It is possible that a more invasive cancer will have higher detectable cytokine levels. An ideal example to investigate is endophytic TSCC, which has an ulcerative or invasive growth pattern compared to fungating exophytic TSCC. Several groups have described patterns of growth in TSCC based on clinical exam as well as histopathological features. Grossly, exophytic growth pattern has been described as a papillary mass with a broad base or narrow stalk whereas the endophytic growth pattern is seen in tumors that are deeply infiltrative or ulcerative.19, 30 Furthermore, during analysis of growth patterns and predictive outcomes, some authors have used an exophytic/endophytic ratio; the exophytic component is measured from the surface of the tumor to the level of tongue mucosa, and the endophytic component is determined from the level of the mucosa to the deepest extent of the tumor.31 Endophytic TSCC growth patterns are associated with higher recurrence rate, increased rate of lymph node metastasis, poorer response to chemotherapy and shorter survival.18, 19, 20, 32 Because endophytic versus exophytic growth patterns are not reported in all studies examining TSCC, the prevalence of each type of growth pattern is unknown.
While biomarkers have the potential to improve survival in all forms of OSCC, this study will focus specifically on TSCC. Aside from the rising incidence of the disease and the dismal prognosis, TSCC was also observed as having the highest levels of IL-6 and IL-8 among OSCC patients.13 This supports the findings that levels of IL-6 and IL-8 are correlated with increased tumor burden, poorer prognosis and increased occurrence of metastases.15, 21, 22, 23 A possible link between these elevated cytokines and poor prognosis is angiogenesis, which is also associated with increased risk of metastases and recurrence in OSCC.24, 25, 26 All of the cytokines selected play a role in the angiogenesis cascade and potentially serve as important angiogenic factors in the development of TSCC.27
This study investigates IL-1, IL-6, IL-8, VEGF and TNF-α as potential TSCC salivary biomarkers. To evaluate their potential for early detection in high-risk patients, we include control subjects who smoke and drink. Similarly, we have divided the TSCC cases into endophytic and exophytic TSCC and will compare the mortality between the two groups. We hypothesize that the salivary biomarkers will increase along a spectrum of disease progression and will be highest in the endophytic TSCC group with a significantly increased mortality.
Section snippets
Patient selection
Participants were recruited from Los Angeles County (LAC) + University of Southern California (USC)/University Hospital. Study design was approved by the USC IRB and written consent was obtained. Of the subjects, 18 were diagnosed with TSCC and divided into exophytic (n = 8) and endophytic (n = 10) cancer type, based on physician diagnosis on physical exam. Controls were divided into 4 groups of 14: healthy subjects, subjects that smoked at least 1 pack of cigarettes daily for 2 + years (smoking
Patient characteristics
By physician diagnosis, 10 patients had endophytic cancer growth and 8 had exophytic TSCC, their patient demographics are presented in Table 1. The sixth edition of the American Joint Commission on Cancer Staging Atlas was used to determine the cancer stage and stage grouping of each patient. The average age for endophytic patients upon diagnosis was 55 (SD = 9) and 58 years of age for exophytic patients (SD = 18). Final surgical pathology confirmed all TSCC cases as having invasive squamous cell
Discussion
Identifying sensitive and specific biomarkers for TSCC has the potential to help decrease the morbidity and mortality of the disease. This study identified the proinflammatory proangiogenic cytokines IL-1α, IL-6, IL-8, TNF-α and VEGF-a as potentially important angiogenic factors in TSCC and targets for future screening developments.
IL-1α, IL-6, VEGF-a and TNF-α followed a predictable trend, increasing along the spectrum from controls to TSCC subjects. All cytokines were markedly elevated in the
Conflicts of interest
The authors have no conflicts of interest to disclose.
Acknowledgements
We thank Susan McDonald and Cory White for their help. This work was supported by a grant from Health Research Associates and RAM Capital.
References (32)
The failure patterns of oral cavity squamous cell carcinoma after intensity-modulated radiotherapy – the University of Iowa experience
Int J Radiat Oncol Biol Phys
(2007)- et al.
The incidence of lymph node micrometastases in patients pathologically staged N0 in cancer of oral cavity and oropharynx
Oral Oncol
(2002) Risk factors for the postoperative local recurrence of tongue carcinoma
J Oral Maxillofac Surg
(1994)Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients
Clin Biochem
(2004)Tumor angiogenesis as a prognostic factor in oral cavity tumors
Am J Surg
(1994)Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma
Cancer
(2008)Changing trends in oral squamous cell carcinoma with particular reference to young patients: 1971–2006. The Emory University experience
Head Neck Pathol
(2008)Prognostic factors in the surgical treatment of patients with oral carcinoma
ANZ J Surg
(2009)- SEER Cancer Statistics Review 1975–2007, 2010 [cited 2010 June 9,...
- Rusthoven KE, et al. Survival and patterns of relapse in patients with oral tongue cancer. J Oral Maxillofac Surg...
Occult lymph node metastasis in small oral tongue cancers
Head Neck
Frequency and therapeutic implications of “skip metastases” in the neck from squamous carcinoma of the oral tongue
Head Neck
The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+
Laryngoscope
Nucleic acid-based methods for the detection of cancer
Science
Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma
Arch Otolaryngol Head Neck Surg
Cited by (86)
Saliva as a potential non-invasive liquid biopsy for early and easy diagnosis/prognosis of head and neck cancer
2024, Translational OncologySaliva biomarkers in oral disease
2023, Clinica Chimica ActaAnalyzing chronic disease biomarkers using electrochemical sensors and artificial neural networks
2023, TrAC - Trends in Analytical ChemistryA sensitive impedimetric immunosensor for the detection of Interleukin-8 in nasal epithelial lining fluid of asthma patients
2022, Biosensors and Bioelectronics: XThe role of differentially expressed salivary microRNA in oral squamous cell carcinoma. A systematic review
2021, Archives of Oral Biology